07:00 , Apr 15, 2013 |  BioCentury  |  Strategy

IP armamentarium

With the most stocked clinical pipeline among its RNAi peers, Alnylam Pharmaceuticals Inc. has made the leap from platform to products, building on an IP position that has enabled revenue-generating deals that footed the bill...
07:00 , Oct 1, 2012 |  BC Week In Review  |  Company News

Alnylam, Isis Pharmaceuticals, Tekmira drug delivery news

Alnylam said the U.S. District Court for the District of Massachusetts denied a motion from Tekmira to dismiss for lack of standing five out of six claims in a patent infringement suit filed by Alnylam...
07:00 , Sep 24, 2012 |  BC Week In Review  |  Company News

AlCana, Alnylam, Tekmira drug delivery news

Tekmira said the Massachusetts Superior Court updated its timeline for a suit brought by Tekmira alleging that Alnylam and AlCana misused and exploited trade secrets related to Tekmira's lipid nanoparticle short interfering RNA delivery technology....
07:00 , Sep 24, 2012 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes...
07:00 , Jul 23, 2012 |  BC Week In Review  |  Company News

AlCana, Alnylam, Tekmira drug delivery news

The Massachusetts Superior Court denied a request by Alnylam and AlCana for leave to file motions for summary judgment in a suit brought by Tekmira alleging that Alnylam and AlCana misused and exploited trade secrets...
07:00 , Jun 4, 2012 |  BC Week In Review  |  Company News

AlCana, Tekmira drug delivery news

AlCana said the Supreme Court of British Columbia granted AlCana's motion to stay proceedings in a suit brought by Tekmira until resolution of a separate suit filed by Tekmira in Massachusetts Superior Court. In the...
07:00 , Mar 12, 2012 |  BC Week In Review  |  Company News

Alnylam, Isis Pharmaceuticals, Tekmira drug delivery news

Tekmira filed a motion to dismiss for lack of standing five out of six claims in a patent infringement suit filed by Alnylam and Isis in the U.S. District Court for the District of Massachusetts...
08:00 , Jan 23, 2012 |  BC Week In Review  |  Company News

Alnylam, Isis, Tekmira drug delivery news

Alnylam and Isis filed suit in the U.S. District Court for the District of Massachusetts alleging that Tekmira infringed Alnylam's patents covering its siRNA and lipid nanoparticle drug delivery technologies. Alnylam said that by providing...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

AlCana, Tekmira drug delivery news

The Supreme Court of British Columbia granted Tekmira's motion for a preliminary injunction against individuals at AlCana in a November suit filed by Tekmira, which alleges the defendants downloaded confidential documents from Tekmira's electronic document...
08:00 , Nov 21, 2011 |  BC Week In Review  |  Company News

AlCana, Alnylam, Tekmira drug delivery news

Tekmira filed suit against individuals at AlCana in the Supreme Court of British Columbia alleging they downloaded confidential documents from Tekmira's electronic document management system related to the company's lipid nanoparticle short interfering RNA delivery...